Cathie Wood Bites Back as Stocks Tumble: Tesla, Iridium, Intellia

Cathie Wood sees opportunity amidst falling stocks. Ark Invest makes notable purchases, focusing on Tesla, Iridium, and Intellia Therapeutics, despite their recent struggles. Investors remain cautious but optimistic about potential rebounds.

Date: 22-03-2025

AI Rating: 5

Investor Insights on Recent Stock Activity

The report reveals significant stock activity involving three companies: Tesla, Iridium Communications, and Intellia Therapeutics. Cathie Wood's active buying amidst the downturn suggests a strategic confidence in potential rebounds for these companies.

Tesla has recently faced challenges, shedding over half its peak value, alongside missing profit estimates in three of the last four quarters. However, signs of optimism arise as analysts predict a return to double-digit growth this year, particularly with new affordable models and advancements in self-driving technology likely driving sales.

Iridium Communications, on the other hand, has seen recent setbacks, having surrendered a third of its value over the past year. The company has registered modest subscriber growth of 8% but is forecasted to deliver lackluster service revenue growth of only 5% to 7%. Concerns regarding intensified competition further cast doubt over its near-term performance.

Intellia Therapeutics has also experienced significant declines, with a staggering 96% drop in stock value since its peak. The initiation of bullish coverage by analysts might indicate future potential, but the recent sharp reduction in price targets heightens risk perception. Although the company's gene-editing technology shows promise, a road to recovery appears challenging.

Overall, while Cathie Wood's purchases suggest confidence in these growth stocks' future recovery, all companies are currently exhibiting pressures that could affect stock prices negatively in the short term.

Stocks: TSLA IRDM NTLA